Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pherin develops vomeropherins for anxiety

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

Solvay acquires betahistine rights

March 15, 1996

Alpha2-adrenoceptor antagonists with neuroprotective effects

March 15, 1996

Astra antioxidants for hypoxia

March 15, 1996

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Antioxidants to treat Alzheimer's disease?

March 15, 1996

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Myloral development update

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...